8-K
filed August 19, 2024, 7:59 PM ET
ticker AHCO
CIK 0001725255
leadership
confidence high
sentiment neutral
materiality 0.40
AdaptHealth COO Shaw Rietkerk to step down, named Chief Business Officer
AdaptHealth Corp.
- Shaw Rietkerk informed by AdaptHealth on Aug 13, 2024 of planned transition to Chief Business Officer.
- Rietkerk will cease serving as COO by end of September 2024; new role effective thereafter.
- Company and Rietkerk are currently negotiating terms of the transition.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001104659-24-090892
- form_type
- 8-K
- ticker
- AHCO
- cik
- 0001725255
- company_name
- AdaptHealth Corp.
- filed_at
- 2024-08-19T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:14.287589+00:00
- generated_at
- 2026-05-31T08:41:33.244730+00:00
- sec_items
- ["5.02"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.4
- calibrated_materiality_score
- 0.4
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001104659-24-090892
- json_url
- https://secwatch.observer/filing/0001104659-24-090892.json
- markdown_url
- https://secwatch.observer/filing/0001104659-24-090892.md
- text_url
- https://secwatch.observer/filing/0001104659-24-090892.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1725255/000110465924090892/0001104659-24-090892-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1725255/000110465924090892/tm2422042d1_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
Cornerstone Building Brands, Inc.
Cornerstone Building Brands names Richard Dirkson as Corporate Controller; CAO departs
Cornerstone Building Brands, Inc.
June 2, 2026, 10:32 AM ET
leadership
Items 5.02, 5.07
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On August 13, 2024, AdaptHealth Corp. (the “Company”) informed Shaw Rietkerk of its intention to transition him to a new position as the Company’s Chief Business Officer, by the end of September, 2024, following which Mr. Rietkerk will no longer serve as the Company’s Chief Operating Officer.
Comparable filing
On May 27, 2026, the Company appointed Richard Dirkson as Senior Vice President, Corporate Controller (principal accounting officer) of the Company, effective May 28, 2026.
Filing page
SEC filing
ONCY
Oncolytics appoints Steve Glover to board, promotes John McAdory to COO
ONCOLYTICS BIOTECH INC
June 2, 2026, 9:02 AM ET
leadership
Items 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On August 13, 2024, AdaptHealth Corp. (the “Company”) informed Shaw Rietkerk of its intention to transition him to a new position as the Company’s Chief Business Officer, by the end of September, 2024, following which Mr. Rietkerk will no longer serve as the Company’s Chief Operating Officer.
Comparable filing
appointed John McAdory as Chief Operating Officer of the Company
Filing page
SEC filing
ACHV
Achieve Life Sciences appoints Jeff Farrow and Dr. Reid Waldman to Board
ACHIEVE LIFE SCIENCES, INC.
June 2, 2026, 8:51 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On August 13, 2024, AdaptHealth Corp. (the “Company”) informed Shaw Rietkerk of its intention to transition him to a new position as the Company’s Chief Business Officer, by the end of September, 2024, following which Mr. Rietkerk will no longer serve as the Company’s Chief Operating Officer.
Comparable filing
the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.
Filing page
SEC filing
GOOD
Gladstone Commercial elects George Stelljes as director; board expands to eight
GLADSTONE COMMERCIAL CORP
June 2, 2026, 8:45 AM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On August 13, 2024, AdaptHealth Corp. (the “Company”) informed Shaw Rietkerk of its intention to transition him to a new position as the Company’s Chief Business Officer, by the end of September, 2024, following which Mr. Rietkerk will no longer serve as the Company’s Chief Operating Officer.
Comparable filing
On June 1, 2026, the Board of Directors (the “Board”) of Gladstone Commercial Corporation (the “Company”) elected George “Chip” Stelljes, III to the Board, effective June 1, 2026.
Filing page
SEC filing
GAIN
Gladstone Investment Elects George Stelljes to Board, Expands to 8 Directors
GLADSTONE INVESTMENT CORPORATION\DE
June 2, 2026, 8:45 AM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On August 13, 2024, AdaptHealth Corp. (the “Company”) informed Shaw Rietkerk of its intention to transition him to a new position as the Company’s Chief Business Officer, by the end of September, 2024, following which Mr. Rietkerk will no longer serve as the Company’s Chief Operating Officer.
Comparable filing
On June 1, 2026, the Board of Directors (the “Board”) of Gladstone Investment Corporation (the “Company”) elected George “Chip” Stelljes, III to the Board, effective June 1, 2026.
Filing page
SEC filing
OSCR
Oscar Health Co-Founder Schlosser transitions from CTO to Advisor to CEO
Oscar Health, Inc.
June 2, 2026, 6:31 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On August 13, 2024, AdaptHealth Corp. (the “Company”) informed Shaw Rietkerk of its intention to transition him to a new position as the Company’s Chief Business Officer, by the end of September, 2024, following which Mr. Rietkerk will no longer serve as the Company’s Chief Operating Officer.
Comparable filing
Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.
Filing page
SEC filing
PAGP
Plains GP Holdings announces CAO succession: Montgomery promoted, Herbold retiring
PLAINS GP HOLDINGS LP
June 2, 2026, 6:05 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On August 13, 2024, AdaptHealth Corp. (the “Company”) informed Shaw Rietkerk of its intention to transition him to a new position as the Company’s Chief Business Officer, by the end of September, 2024, following which Mr. Rietkerk will no longer serve as the Company’s Chief Operating Officer.
Comparable filing
effective September 1, 2026, Russ Montgomery will be promoted to the position of Vice President, Accounting and Chief Accounting Officer of Plains All American GP LLC, the general partner of PAA, and PAA GP Holdings LLC, the general partner of PAGP.
Filing page
SEC filing
PAA
Plains All American announces CAO retirement and Montgomery promotion effective Sep 1, 2026
PLAINS ALL AMERICAN PIPELINE LP
June 2, 2026, 6:03 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On August 13, 2024, AdaptHealth Corp. (the “Company”) informed Shaw Rietkerk of its intention to transition him to a new position as the Company’s Chief Business Officer, by the end of September, 2024, following which Mr. Rietkerk will no longer serve as the Company’s Chief Operating Officer.
Comparable filing
Chris Herbold, who previously served as Senior Vice President, Finance and Chief Accounting Officer of PAA and PAGP, is retiring from the company on August 31, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.